-

Xerox and Vortran Medical Partnering to Mass Produce Disposable Ventilators

NORWALK, Conn. & SACRAMENTO, Calif.--(BUSINESS WIRE)--Xerox Holdings Corporation (NYSE: XRX) and Vortran Medical Technology are teaming up to speed and scale production of Vortran’s GO2Vent ventilator and related Airway Pressure Monitor (APM-Plus) for hospitals and emergency response units fighting the battle against COVID-19.

The two companies expect to work together to quickly respond to the shortage of critical ventilation equipment necessary to support patients breathing. Assuming a stable supply of essential parts, the companies will be rapidly scaling up production from approximately 40,000 ventilators in April to between 150,000 and 200,000 ventilators a month by June. Together, Xerox and Vortran could produce as many as 1 million ventilators in the coming months.

While the GO2Vent is not a replacement for ventilators found in intensive care units (ICUs), it is widely used in emergency situations, inter-hospital transport and MRIs. Given the shortage of ICU-grade ventilators, medical professionals are utilizing tools like this and other technology to support patients who do not yet or no longer need an ICU-level breathing device, which can be freed up for another patient.

“Our smartest minds met (virtually) with Vortran’s smartest minds and figured out how to mass produce this critical technology,” said John Visentin, vice chairman and chief executive officer, Xerox. “We want to help make sure doctors, nurses and paramedics on the frontlines have the resources they need to help the rising number of patients with COVID-19.”

Xerox plans to manufacture these FDA-approved ventilators and APM-Plus devices at its facility outside of Rochester, NY, where the company was founded and maintains a large presence. Vortran will continue to manufacture ventilators at its current facility in Sacramento, CA.

“The partnership with Xerox has one clear goal – to help save as many lives as possible. With Vortran’s proven technology and Xerox’s ability to hyper-scale manufacturing, we believe we can supply healthcare providers as many as 1 million ventilators in the coming months,” said Vortran Co-founder and CEO, Gordon A. Wong, M.D. “For all of us, this will be the most important thing we ever do.”

Vortran’s GO2Vent was designed for emergency use, natural disasters and disease outbreaks such as the COVID-19 pandemic. A gas-operated, disposable ventilator that can be set-up within minutes and discarded after use by a single patient, it provides support via a secure airway and can be operated on a compressor, oxygen or air with a minimum of 10 liters per minute flow rates.

The GO2Vent can provide continuous ventilatory support for up to 30 days and operates independent of Vortran’s APM-Plus. The APM-Plus is a battery operated, portable device that connects to a GO2Vent and provides enhanced monitoring of patient status and key respiratory parameters. Given the need to confirm key supplies, the companies are actively assessing how quickly production can ramp for the APM-Plus devices.

In addition to scaling up production of the GO2Vent and APM-Plus, Xerox and Vortran expect to compile and analyze data and feedback from healthcare professionals on the frontlines of the battle against COVID-19 in order to design and mass produce external, in-line modifications that can be added to the GO2Vent to expand the potential applications of this life-saving equipment.

Both Xerox and Vortran will distribute the products.

About Xerox

Xerox Holdings Corporation makes every day work better. We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. Learn how that innovation continues at xerox.com.

About Vortran

VORTRAN Medical Technology has been providing medical device excellence since 1983. We are a research, development, and manufacturing company of advanced medical respiratory and ambulatory devices. We serve domestic and international markets with a superior line of products for hospitals, emergency medical services (EMS), disaster preparedness, and MRI/CT applications in hospitals, acute care, post acute, homecare and EMS situations.

Note: To receive RSS news feeds, visit https://www.news.xerox.com. For open commentary, industry perspectives and views, visit http://twitter.com/xerox, http://www.facebook.com/XeroxCorp, https://www.instagram.com/xerox/, http://www.linkedin.com/company/xerox, http://www.youtube.com/XeroxCorp.

Xerox® is a trademark of Xerox Corporation in the United States and/or other countries.

Contacts

Xerox Media Contact:
Caroline Gransee-Linsey, Xerox, +1-203-849-2359, Caroline.Gransee-Linsey@xerox.com

Vortran Media Contact:
Elizabeth Wise, McGinn and Company, +1-202-868-1579, ewise@mcginnandcompany.com

Xerox Holdings Corporation

NYSE:XRX

Release Summary
Xerox Holdings Corporation (NYSE: XRX) and Vortran Medical Technology are teaming up to speed and scale production of Vortran’s GO2Vent ventilator.
Release Versions
$Cashtags

Contacts

Xerox Media Contact:
Caroline Gransee-Linsey, Xerox, +1-203-849-2359, Caroline.Gransee-Linsey@xerox.com

Vortran Media Contact:
Elizabeth Wise, McGinn and Company, +1-202-868-1579, ewise@mcginnandcompany.com

Social Media Profiles
More News From Xerox Holdings Corporation

Xerox Announces Exchange Transaction to Extend Portion of 2028 Debt Maturities and Reduce Overall Debt

NORWALK, Conn.--(BUSINESS WIRE)--Xerox Holdings Corporation (NASDAQ: XRX) today announced an exchange transaction (the “Exchange Transaction”) that will address approximately $174 million of its senior notes due in 2028 (the “2028 Notes”), extending those maturities to 2030 while reducing overall debt principal and preserving cash. The transaction represents another step in the company’s ongoing efforts to strengthen its balance sheet and reduce leverage. “Following the open market purchases ea...

Xerox Releases Third-Quarter Results

NORWALK, Conn.--(BUSINESS WIRE)--Xerox Holdings Corporation (NASDAQ: XRX) today announced its 2026 third-quarter results. “This quarter, Print equipment revenue grew and adjusted operating margin doubled as we continued to execute against our three priorities: stabilize revenue, increase profitability and reduce leverage,” said Louie Pastor, chief executive officer at Xerox. “We are seeing results in the areas where we have focused our execution, but the headwinds affecting our outlook have int...

Xerox Holdings Corporation Plans Webcast to Discuss 2026 Third-Quarter Results

NORWALK, Conn.--(BUSINESS WIRE)--Xerox Holdings Corporation (NASDAQ: XRX) will host a live webcast at 8:00 a.m. ET on Thursday, October 29th, to discuss the company’s 2026 third-quarter results. A news release containing this information will be issued earlier that day at 6:30 a.m. ET. WHEN:   8:00 a.m. ET, Thursday, October 29th, 2026       WHAT:   Review of Xerox’s 2026 third-quarter results       WHO:   Louie Pastor, chief executive officer, Xerox     Chuck Butler, chief financial officer, X...
Back to Newsroom